Hikma Ventures Invests In Octave Bioscience, A Precision Care Platform For Multiple Sclerosis And Other Neurodegenerative Diseases
Round Type
Funding Round
Menlo ParkBiotechnologyHealthcareInvestors
Description
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that its venture capital arm, Hikma Ventures, has invested in Octave Bioscience, the developer of a first-of-its-kind platform to accurately and objectively measure and help manage complex and high-cost neurodegenerative diseases, starting with multiple sclerosis (MS).
Quick answer
Octave Bioscience raised an undisclosed amount in a Funding Round round, dated July 26, 2023. Investors: Hikma Ventures and Hikma Pharmaceuticals PLC. Octave Bioscience is based in Menlo Park, California, United States.
- How much did Octave Bioscience raise?
- Octave Bioscience raised an undisclosed amount in a Funding Round round on July 26, 2023.
- Who invested in Octave Bioscience?
- Hikma Ventures and Hikma Pharmaceuticals PLC are named as investors in this round.
- What does Octave Bioscience do?
- Octave Bioscience, Inc. is a commercial growth stage precision medicine company pioneering biomarker-driven solutions for neurodegenerative diseases, with an initial focus on Multiple Sclerosis, and Parkinson’s Disease..
- Where is Octave Bioscience based and how big is it?
- Octave Bioscience is based in Menlo Park, California, United States. Fundz records about 83 employees.
- Who are the decision-makers at Octave Bioscience?
- Fundz holds 2 contacts at Octave Bioscience, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Octave Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Cellectar raised $25M on September 8, 2023.
- HeartSciences raised $1M (Seed) on September 7, 2023.
- Arthrosi Therapeutics raised $7M on September 5, 2023.
- Cellectar raised $103M (Post-IPO Equity) on September 5, 2023.
- Cardio Flow, Inc. raised $100K (Seed) on September 1, 2023.
- Beta Bionics raised $99M on August 28, 2023.
Who to call at Octave Bioscience, and when
A new round usually means Octave Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Octave Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Octave Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Octave Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Octave Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Octave Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.